Journal article
Health-related quality of life in patients with cutaneous T-cell lymphoma?
International journal of dermatology, Vol.57(11), pp.1314-1319
11/2018
DOI: 10.1111/ijd.14132
PMID: 30074622
Abstract
Little is currently known about health-related quality of life (HRQoL) of patients with cutaneous T-cell lymphoma (CTCL), a condition characterized by chronic, pruritic, visible lesions, features which may be uniquely influential.
The aim of this study was to establish baseline HRQoL data for patients with CTCL and identify its influencing factors.
Prospective, nonblinded survey design utilizing questionnaires including panels of QoL indices obtained from 105 patients with mycosis fungoides, Sezary syndrome, and CD30+ lymphoproliferative disorder. Chart review correlated QoL with year of disease onset/diagnosis, type/stage of disease, current/past therapies, and medical/psychiatric diagnoses.
Psychiatric condition was significantly associated with symptoms (P < 0.01), emotions (P < 0.01), and functioning (P < 0.03) subscales along with overall composite measure (P < 0.01). High-grade systemic therapy (OR = 5.28) showed greater increase in odds of a lower health state than low grade (OR = 1.54). The number of medical comorbidities was significantly related to itching (P < 0.01). Increased age was a protective factor with respect to the emotions (P < 0.01), functioning (P < 0.01), and overall composite (P < 0.01) but not predictive of symptoms. Lower income was associated with higher bother on the symptoms subscale.
HRQoL in CTCL appears related to a number of factors, including presence of a psychiatric condition, use of systemic (particularly high grade) therapy, number of medical comorbidities, and income.
Details
- Title: Subtitle
- Health-related quality of life in patients with cutaneous T-cell lymphoma?
- Creators
- Heather M Holahan - Rutgers-New Jersey Medical School, Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USARonda S Farah - Department of Dermatology, University of Minnesota, Minneapolis, MN, USASara Fitz - Medical Associates Clinic & Health Plans, Dubuque, IA, USASarah L Mott - University of Iowa Hospitals and Clinics, Holden Comprehensive Cancer Center, Iowa City, IA, USANkanyezi N Ferguson - Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USAJulie McKillip - Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USABrian Link - Department of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USAVincent Liu - Departments of Dermatology and Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- International journal of dermatology, Vol.57(11), pp.1314-1319
- Publisher
- England
- DOI
- 10.1111/ijd.14132
- PMID
- 30074622
- ISSN
- 0011-9059
- eISSN
- 1365-4632
- Grant note
- P30 CA086862 / NCI NIH HHS
- Language
- English
- Date published
- 11/2018
- Academic Unit
- Dermatology; Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
- Record Identifier
- 9984025455102771
Metrics
25 Record Views